Treatment of Tempromandibular Joint Anterior Disc Displacement With Different Materials

NCT06441279 — Not applicable, Completed, 60 participants, Mansoura University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Hyaluronic Acid Versus Platelet Lysate in The Treatment of Temporomandibular Joint Anterior Disc Displacement With Reduction: A Randomized Clinical Trial

RegistryNCT06441279
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment60 (Actual)
SponsorMansoura University (Other)
ConditionsTMJ Disc Disorder
Interventionsintra-articular injection with Platelet lysate (PL)., intra-articular injection with Hyaluronic Acid. (Procedure)
Datesstart 2024-04-01, primary completion 2024-10-01, completion 2024-10-01, first posted 2024-06-04, last updated 2024-12-04
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for TMJ Disc Disorder All trials of intra-articular injection with Platelet lysate (PL). All trials of intra-articular injection with Hyaluronic Acid.

-Summary

comparing the clinical efficacy of intra-articular injection of platelet lysate (PL), versus Hyaluronic Acid after arthrocentesis in the management of patients with anterior disc displacement with reduction.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
group 1ExperimentalProcedure: intra-articular injection with Platelet lysate (PL).30 patients that will have intra-articular injection of 2 ml of Platelet lysate (PL).
group 2ExperimentalProcedure: intra-articular injection with Hyaluronic Acid.30 patients that will have intra-articular injection of Hyaluronic Acid.
  • intra-articular injection with Platelet lysate (PL). (Procedure): 2 ml of Platelet lysate will be deposited into the superior joint space (SJS) in the affected joint at the entry point slowly
  • intra-articular injection with Hyaluronic Acid. (Procedure): 2 ml of Hyaluronic Acid will be deposited into the superior joint space (SJS) in the affected joint at the entry point slowly.

+Outcome measures

Primary outcomes

  • Maximum inter-incisal opening [6 months]: Maximum inter-incisal opening will be measured by Vernier caliper and this will be recorded by photographs.

+Eligibility

Sex: All, ages: 18 Years to 60 Years, accepts healthy volunteers

Inclusion Criteria:

* Patients that will be diagnosed with anterior disc displacement with reduction (ADDWR) both clinically and through magnetic resonance imaging scan (MRI).
* Patients who will not respond to a previous conservative therapy.
* Patients with pain in temporomandibular joints.
* Patients with normal or limitation in mouth opening.
* Patients with clicking sound.

Exclusion Criteria:

* Patients with previous invasive TMJ surgical procedures.
* Patients with inflammatory or connective tissue diseases.
* Patients with neurologic disorders.
* Patients with history of bony or fibrous adhesion.
* Patients having gross mechanical restrictions and condylar fractures.
* Patients with psychological problems.
* Patients receiving anti-coagulation treatment, non-steroidal anti-inflammatory drugs within 48 hours pre-operatively, corticosteroid injection at the treatment site within one month or systemic use of corticosteroids within 2 weeks.

+Locations (1)

FacilityCityCountryStatus
Heba ElsheikhMansoura, EgyptEgypt

+Publications

  • Results publication: Elsheikh HA, Abdel-Rahman FH, Khaled N, Abdelsameaa SE. Platelet lysate versus hyaluronic acid after arthrocentesis in the treatment of temporomandibular joint anterior disc displacement with reduction: a randomized clinical trial. Odontology. 2026 Apr 30. doi: 10.1007/s10266-026-01397-1. Online ahead of print. PMID 42062696